Metraipolis › archive › dc_795e6804153a

Response to pembrolizumab in a patient with xeroderma pigmentosum, metastatic cutaneous melanoma and multiple squamous cell carcinomas: a case report — Europe PMC PMID:41035837

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41035837
DOI
10.1093/skinhd/vzaf038
License (as archived)
solo-consultazione
Archived
2026-11-10T03:51:25.375Z
SHA-256 of the archived text
81a59882aaea5826883ba1a6d3a89328f15fe26fcb307aff439c42410fd4aa5c
Stable URL of this page
https://metraipolis.com/documento/dc_795e6804153a

How to cite

Response to pembrolizumab in a patient with xeroderma pigmentosum, metastatic cutaneous melanoma and multiple squamous cell carcinomas: a case report — Europe PMC PMID:41035837 — Europe PMC (en), https://europepmc.org/article/MED/41035837 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_795e6804153a (Metraipolis archive dc_795e6804153a, sha256 81a59882aaea5826883ba1a6d3a89328f15fe26fcb307aff439c42410fd4aa5c)
BibTeX
@misc{dc795e6804153a,
  title = {Response to pembrolizumab in a patient with xeroderma pigmentosum, metastatic cutaneous melanoma and multiple squamous cell carcinomas: a case report — Europe PMC PMID:41035837},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41035837},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_795e6804153a; sha256 81a59882aaea5826883ba1a6d3a89328f15fe26fcb307aff439c42410fd4aa5c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41035837. Agents can read the archived copy with the MCP tool read_document.